Efficiency of subconjunctival bevacizumab on pterygium

Background: To evaluate the effect and complications of subconjunctival bevacizumab (Avastin ®) on primary and recurrent pterygium. Methods: This prospective study included sixteen patients with pterygium, who received subconjunctival injection of bevacizumab (1.25 mg/0,1 mL). Digital photo...

Full description

Bibliographic Details
Main Authors: Alenka Lavrič, Brigita Drnovšek Olup
Format: Article
Language:English
Published: Slovenian Medical Association 2012-06-01
Series:Zdravniški Vestnik
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/934